Enlivex Ltd.
ENLVNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $4.33M
- P/E (TTM)
- 0.00
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.21$15.15
- Volume (live)
- -
- Avg. volume (3M)
- 1.65M
Enlivex (ENLV) Stock Price & Financial Analysis
Enlivex Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.21 - $0.24 |
|---|---|
| 52-Week High | $15.15 |
| 52-Week Low | $0.21 |
| Open | $0.22 |
| Volume (last close) | 560.29K |
| Average Volume (3M) | 1.65M |
| 50-Day MA | $1.05 |
|---|---|
| 200-Day MA | $4.53 |
| 1-Year Change | −79.53% |
| Market Cap | 4.33M |
|---|---|
| Shares Outstanding | 19.33M |
| P/E Ratio (TTM) | 0.00 |
| Price to Book (P/B) | 0.00 |
| EV/EBITDA | -0.79 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Enlivex at a Glance
As of the Oct 15, 2026 close, Enlivex (ENLV) has a market capitalization of $4.33M. It has no meaningful P/E ratio because trailing earnings are negative.
As of its latest reported balance sheet, it holds $5.52M in cash and securities against $17.25M of debt, a net debt position of $11.73M.
Enlivex does not currently pay a dividend.
The share price is down 79.5% over the past year. At $0.22 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $0.21 to $15.15, below its 200-day moving average of $4.53.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Enlivex
What is the current stock price for ENLV?
As of the Oct 15, 2026 close, ENLV stock trades at $0.22. The 52-week range is $0.21–$15.15, with a day range of $0.21–$0.24.
What is the P/E ratio for ENLV?
The P/E ratio (Price-to-Earnings) for ENLV is shown in the Key Statistics section. This valuation metric helps compare Enlivex Ltd. to industry peers.
Does ENLV pay dividends?
Enlivex does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ENLV?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for ENLV is Buy.
What is the market cap of ENLV?
As of the Oct 15, 2026 close, Enlivex's market capitalization is $4.3M, classifying it as a micro-cap company. Enlivex operates in the Healthcare sector within the Biotechnology industry.